Delivery Order SPE2DB22D2211-SPE2DB24FMNL5
- Not listed
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,300.87, is for the supply of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of fluticasone propionate HFA 110 mcg inhalers. The $1,102.23 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.58, is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,592.45 firm-fixed-price delivery order is for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.59 delivery order is for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers. The contract has a firm fixed price and is set to run through November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of fluticasone propionate HFA 110 mcg 12 gram inhalers. The $3,617.40 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of fluticasone propionate HFA 110 mcg aerosol inhalers. The firm-fixed-price delivery order, valued at $2,323.99, has a completion date of May 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical products and supplies, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.96 firm fixed-price delivery order is for the supply of fluticasone propionate HFA 110 mcg 12 gm inhalation aerosol, a prescription medication. The contract has an ultimate completion date of September 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Fluticasone Propionate HFA 110 mcg 12 gram inhalers. The $1,356.56 firm-fixed-price delivery order contract has a completion date of July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,508.41 for the supply of fluticasone propionate HFA 110 mcg 12 g inhalers. The contract was awarded by the Defense Logistics Agency (DLA), which is the defense agency responsible for providing medical supplies and equipment to military healthcare systems. The contract does not have a set-aside designation, indicating it was open competition. Amerisourcebergen holds a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMNL5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,045.14 firm fixed-price delivery order contract is for the supply of fluticasone propionate HFA 110 mcg 12 gm inhalers. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen maintains a significant federal contracting presence, with additional IDCs held with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/8/24 |